2.7.7.35	(1S)-1-(1H-benzimidazol-2-yl)-N-[(1-benzofuran-3-yl)methyl]-2-methylpropan-1-amine	i.e. ZINC096223736, inhibitor identified by virtual screening; i.e. ZINC121003678, inhibitor identified by virtual screening, displays high number of hydrophobic contacts	260677	
2.7.7.35	(2S)-2-(1H-benzimidazol-2-yl)-N-[(3-cyclopropyl-1H-pyrazol-5-yl)methyl]pyrrolidine-1-carboxamide	i.e. ZINC426746041, inhibitor identified by virtual screening	260736	
2.7.7.35	(5-amino-4-chloro-1H-pyrazol-3-yl)[(2S)-2-(5-fluoro-1H-benzimidazol-2-yl)pyrrolidin-1-yl]methanone	i.e. ZINC217844024, inhibitor identified by virtual screening, displays high amount of hydrogen bonding	260813	
2.7.7.35	2-[[(1H-benzimidazol-2-yl)methyl]sulfanyl]quinazolin-4-ol	i.e. ZINC082673, inhibitor identified by virtual screening, displays high number of hydrophobic contacts	261213	
2.7.7.35	4-(3-methoxypropyl)-5-[[(2S)-1-(2-methyl-3H-indol-3-yl)-1-oxopropan-2-yl]sulfanyl]-2,4-dihydro-3H-1,2,4-triazol-3-one	i.e.ZINC014116837, inhibitor identified by virtual screening, displays high number of hydrophobic contacts	261415	
2.7.7.35	ADP	weak, ADP-ribose phosphorolysis	13	
2.7.7.35	ADP-ribose	competitive to phosphate	402	
2.7.7.35	Ag2+	-	1041	
2.7.7.35	AMP	kinetics	30	
2.7.7.35	AMP	-	30